Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2018-12, Vol.183 (5), p.842-845
Hauptverfasser:	Ogawa, Miho, Yokoyama, Kazuaki, Hirano, Mitsuhito, Jimbo, Koji, Ochi, Kiyosumi, Kawamata, Toyotaka, Ohno, Nobuhiro, Shimizu, Eigo, Yokoyama, Nozomi, Yamaguchi, Rui, Imoto, Seiya, Uchimaru, Kaoru, Takahashi, Naoto, Miyano, Satoru, Imai, Yoichi, Tojo, Arinobu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use BCR‐ABL1 mutation Blast Crisis Bone marrow Bone Marrow Neoplasms - drug therapy Central nervous system Central Nervous System Neoplasms - drug therapy chronic myeloid leukaemia Chronic myeloid leukemia Dasatinib - administration & dosage deep sequencing Drug Administration Schedule Drug Substitution Fatal Outcome Female Hematology Humans Imatinib Mesylate - therapeutic use Imidazoles - administration & dosage in vivo bioavailability of nilotinib isolated central nervous system relapse Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Middle Aged Pyridazines - administration & dosage Pyrimidines - administration & dosage Recurrence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!